Player is loading...
Introduction
Pr. Dr. S. Ferrari, Geneva
Friday, May 13, 2022 · 11:45 a.m. · 01m 38s
Embed
Embed code is not allowed
This talk is part of a Private webcast, embeding is not permited.Transcriptions
Note: this content has been automatically generated.
00:00:04
and so we can move now to uh uh
00:00:08
the industry sponsored a symposium a sponsored by um
00:00:13
u. c. d. and um we will discuss all for the latest uh keep around the block
00:00:20
um ramos holes in my lab uh which as you know has been approved or
00:00:24
uh for treatment of severe osteoporosis in switzerland was reimbursement
00:00:29
since february of this year and it's my great pleasure uh to introduce professor a panty line bad
00:00:36
oh by the way also happens to be a very good friend and with whom we have a collaborate on on many clinical studies
00:00:43
i've been to down there is a professor of
00:00:45
endocrinology uh uh in our wrists in denmark um she's
00:00:50
had interested bone feel for i guess even as long
00:00:54
as i do or even not longer spin former president
00:00:57
off the e. c. t. s. uh she's done a a number of importance ignore work or to clean the
00:01:04
genetics of osteoporosis but of course also involving very important
00:01:08
clinical trials um one of them is one of the three
00:01:13
a seminal a clinical trials with formal souls in ab
00:01:17
against surprised that the structure study the chip optional and said
00:01:21
so it's a great pleasure to have you been to to present does the clinical data with the latest clinical data
00:01:27
which will also zoom out and then i will uh shortly uh discuss with you uh
Conference Program
Introduction
Pr. Dr. S. Ferrari, Geneva
May 13, 2022 · 11:45 a.m.
Romosozumab clinical data
Pr. Dr. B. Langdahl, Aarhus, DK
May 13, 2022 · 11:50 a.m.
118 views
Romosozumab limitation (CH): challenges and opportunities
Pr. Dr. S. Ferrari, Geneva
May 13, 2022 · 12:25 p.m.
Questions & Answers Session
May 13, 2022 · 12:40 p.m.
Short- or long-term denosumab therapy? Part 1
Dr. J. Everts-Graber, Bern
May 13, 2022 · 1:37 p.m.
401 views
Short- or long-term denosumab therapy? Part 2
Pr. Dr. S. Ferrari, Geneva
May 13, 2022 · 1:52 p.m.
Clinical debate: Short- or long-term denosumab therapy?
May 13, 2022 · 2:02 p.m.
113 views
